Narrow your search

Library

Odisee (6)

Thomas More Kempen (6)

Thomas More Mechelen (6)

UCLL (6)

VIVES (6)

LUCA School of Arts (4)

KU Leuven (3)

ULB (3)

ULiège (3)

VUB (3)

More...

Resource type

book (6)


Language

English (6)


Year
From To Submit

2013 (1)

2012 (1)

2011 (1)

2010 (2)

2006 (1)

Listing 1 - 6 of 6
Sort by
Fibrinolytic and antithrombotic therapy : theory, practice, and management
Authors: ---
ISBN: 0197561950 1280837837 019974906X 1429402733 9780199749065 9781429402736 9780195155648 0195155645 Year: 2006 Publisher: Oxford ; New York : Oxford University Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Thrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual information on fibrinolytic and antithrombotic therapy, but also the means to apply it to everyday decision making and patient care. Focusing on management guidelines and critical pathways, the text stresses practicality and usability. It will be a valuable resource for the wide range of clinicians involved in the care of patients with these disorders.


Book
Antithrombotic therapy in the prevention of ischemic stroke
Authors: ---
ISBN: 0199774447 9780199774449 9780195394320 0195394321 Year: 2010 Publisher: Oxford New York

Loading...
Export citation

Choose an application

Bookmark

Abstract

Stroke is the most common cause of adult mortality in the United States. Antithrombotic agents form the mainstay of stroke prevention. Aspirin produces a modest reduction in the risk of second stroke and transient ischemic attack (TIA, mini-stroke) and is widely recommended for initial therapy. The thienopyridines (Ticlid) and clopodogrel (Plavix) are alternatives for secondary prevention in patients who do not respond to or cannot take aspirin. They are no more effective than aspirin and have been associated with thrombotic thrombocytopenic purpura. The combination of aspirin and extended-rel


Book
Antithrombotic Drug Therapy in Cardiovascular Disease
Authors: ---
ISBN: 1607613468 1603272348 9786612828171 1603272356 1627037977 1282828177 Year: 2010 Publisher: Totowa, NJ : Humana Press : Imprint: Humana,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).


Book
Fibrinolytic Bacterial Enzymes with Thrombolytic Activity
Author:
ISBN: 3642249795 3642249809 9786613573186 1280395265 Year: 2012 Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Stress, high blood pressure, smoking, pollution, fast foods, overweight, excessive travelling, surgery, less movement are common features in our modern life. These features are risky for blood clotting disorders. According to WHO, over 29% of the total mortalities worldwide are due to thrombosis. By the year, 2020 cardiovascular diseases (CVDs) may cause an estimated 25 million deaths per year, thus antithrombotic therapy is of great interest. The available thrombolytic agents such as urokinase are highly expensive, antigenic, quite unspecific, pyretogenic and hemorrhagenic. Therefore, the production of fibrinolysing enzymes, which rapidly dissolute thrombi within the vascular tree, without the detriments by microorganisms, as described in this book, is the desirable aim of today’s research.


Book
Thromboembolism in Orthopedic Surgery
Author:
ISBN: 1447143353 1447143361 1447159616 Year: 2013 Publisher: London : Springer London : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Thromboembolism in Orthopedic Surgery reviews the main topics in thromboprophylaxis around orthopedic surgery, from a general view of the problems with the disease and highlighting them in orthopedics to the new specific protocols involving, for example, new oral anticoagulants. The wide scope of this book covers topics ranging from The prevalence of the venous thromboembolism in each procedure and the risk factors to bear in mind in each one. The diagnosis and treatment of venous thromboembolism. The methods for thromboprophylaxis. Anaesthetic implications for thromboprophylaxis and, also, main implications of the application of antithrombotic protocols in the anaesthetic practice are covered. An approach based on dividing the orthopedic procedures according to their own thrombotic risk was used, thus providing separate protocols for each thromboprophylaxis: high risk, day surgery procedures and “special” surgical procedures. Finally, we review the problems involving the perioperatory management of antiaggregated and anticoagulated patients, with a special part in hip fracture surgery. The multidisciplinary approach and contributions from a panel of expert international  authors have come together to create an excellent teaching resource, and essential guide to improving the application of thromboprophylaxis in orthopedic surgery.


Book
tPA for stroke : the story of a controversial drug
Authors: ---
ISBN: 1283121263 9786613121264 0199780943 9780199780945 9780195393927 0195393929 Year: 2011 Publisher: New York : Oxford University Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua

Listing 1 - 6 of 6
Sort by